Your browser doesn't support javascript.
loading
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy.
Wudhikarn, Kitsada; Flynn, Jessica R; Rivière, Isabelle; Gönen, Mithat; Wang, Xiuyan; Senechal, Brigitte; Curran, Kevin J; Roshal, Mikhail; Maslak, Peter G; Geyer, Mark B; Halton, Elizabeth F; Diamonte, Claudia; Davila, Marco L; Sadelain, Michel; Brentjens, Renier J; Park, Jae H.
Afiliación
  • Wudhikarn K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Flynn JR; Research Unit in Translational Hematology, Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Rivière I; Department of Biostatistics and Epidemiology.
  • Gönen M; Cell Therapy and Cell Engineering Center.
  • Wang X; Department of Biostatistics and Epidemiology.
  • Senechal B; Cell Therapy and Cell Engineering Center.
  • Curran KJ; Cell Therapy and Cell Engineering Center.
  • Roshal M; Bone Marrow Transplant Service, Department of Pediatrics.
  • Maslak PG; Cellular Therapeutics Center.
  • Geyer MB; Department of Pediatrics.
  • Halton EF; Hematopathology Service, Department of Pathology.
  • Diamonte C; Immunology Laboratory Service, Department of Laboratory Medicine, and.
  • Davila ML; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Sadelain M; Department of Medicine, Weill Cornell College of Medicine, New York, NY.
  • Brentjens RJ; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Park JH; Department of Medicine, Weill Cornell College of Medicine, New York, NY.
Blood ; 138(7): 531-543, 2021 08 19.
Article en En | MEDLINE | ID: mdl-33851211
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Inmunoterapia Adoptiva / Terapia Recuperativa / Anticuerpos Biespecíficos / Inotuzumab Ozogamicina Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Inmunoterapia Adoptiva / Terapia Recuperativa / Anticuerpos Biespecíficos / Inotuzumab Ozogamicina Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article